Compass Therapeutics Inc.
CMPX | NASDAQ
$1.82
-$0.08 (-4.21%)
At close: Sep 21, 2026, 4:00 PM ET
$1.08
-$0.74 (-40.75%)
Pre-market:
Sep 22, 2026, 8:49 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 850K | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.47M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -1.47M | 850K | n/a | n/a | n/a | n/a |
Operating Income | -72.84M | -56.63M | -50.36M | -41.66M | -81.88M | -27.81M |
Interest Income | 6.35M | 7.3M | 7.9M | 2.36M | 29K | 88K |
Pretax Income | -66.49M | -49.38M | -42.49M | -39.23M | -82.18M | -29.47M |
Net Income | -66.49M | -49.38M | -42.49M | -39.23M | -82.18M | -29.5M |
Selling & General & Admin | 16.87M | 15.13M | 12.24M | 11.66M | 10.93M | 12.91M |
Research & Development | 55.97M | 42.34M | 38.12M | 30M | 20.34M | 14.9M |
Other Expenses | -1.47M | n/a | n/a | n/a | 50.62M | n/a |
Operating Expenses | 71.37M | 57.48M | 50.36M | 41.66M | 81.88M | 27.81M |
Interest Expense | n/a | n/a | n/a | 2.36M | 370K | 908K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 72.84M | 57.48M | 50.36M | 41.66M | 81.88M | 27.81M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 32K |
Shares Outstanding (Basic) | 157.7M | 137.11M | 127.03M | 105.19M | 62.87M | 56.22M |
Shares Outstanding (Diluted) | 157.7M | 137.11M | 127.03M | 105.19M | 62.87M | 56.22M |
EPS (Basic) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 | -0.52 |
EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 | -0.52 |
EBITDA | -65.02M | -47.62M | -40.6M | -34.96M | -80.19M | -25.41M |
EBIT | -66.49M | -49.38M | -42.49M | -36.87M | -81.81M | -27.81M |
Depreciation & Amortization | 1.47M | 1.75M | 1.89M | 1.9M | 1.62M | 2.4M |
Add to Watchlist
Select watchlists to add or remove CMPX